Cwm LLC Has $38,000 Stock Position in Aehr Test Systems (NASDAQ:AEHR)

Key Points

• Cwm LLC significantly reduced its stake in Aehr Test Systems by 95.6%, selling 114,086 shares and leaving it with only 5,269 shares valued at $38,000.
• Various institutional investors have recently increased their positions in Aehr Test Systems, with Invesco Ltd. raising its stake by 7.9% and JPMorgan Chase & Co. by 15.4%.
• Aehr Test Systems reported a quarterly EPS of ($0.01), surpassing analysts’ expectations, but experienced a negative net margin of 6.63% with revenues of $14.1 million.

CWM LLC reduced its position in Aehr Test Systems (NASDAQ:AEHR - Free Report) by 95.6% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,269 shares of the semiconductor company's stock after selling 114,086 shares during the period. CWM LLC's holdings in Aehr Test Systems were worth $38,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the business. Raymond James Financial Inc. bought a new position in shares of Aehr Test Systems in the 4th quarter valued at about $272,000. LPL Financial LLC bought a new position in Aehr Test Systems during the 4th quarter worth $874,000. Vanguard Group Inc. lifted its holdings in Aehr Test Systems by 2.1% in the fourth quarter. Vanguard Group Inc. now owns 2,183,641 shares of the semiconductor company's stock valued at $36,314,000 after buying an additional 44,881 shares during the period. JPMorgan Chase & Co. lifted its holdings in shares of Aehr Test Systems by 15.4% in the 4th quarter. JPMorgan Chase & Co. now owns 15,591 shares of the semiconductor company's stock worth $259,000 after purchasing an additional 2,076 shares in the last quarter. Finally, Geode Capital Management LLC boosted its holdings in Aehr Test Systems by 1.3% during the fourth quarter. Geode Capital Management LLC now owns 647,610 shares of the semiconductor company's stock worth $10,773,000 after purchasing an additional 8,461 shares during the last quarter. Institutional investors and hedge funds own 69.69% of the company's stock.

Insiders Place Their Bets

In related news, VP Alistair N. Sporck sold 3,000 shares of the firm's stock in a transaction on Tuesday, July 15th. The stock was sold at an average price of $14.13, for a total value of $42,390.00. Following the completion of the sale, the vice president directly owned 30,808 shares in the company, valued at $435,317.04. This trade represents a 8.87% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Rhea J. Posedel sold 18,000 shares of the business's stock in a transaction dated Tuesday, July 22nd. The shares were sold at an average price of $19.83, for a total transaction of $356,940.00. Following the completion of the sale, the director owned 71,163 shares of the company's stock, valued at approximately $1,411,162.29. This represents a 20.19% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 30,995 shares of company stock worth $552,185 in the last 90 days. Corporate insiders own 6.20% of the company's stock.

Aehr Test Systems Stock Up 4.0%

AEHR stock traded up $0.73 during midday trading on Thursday, reaching $18.91. 510,726 shares of the company's stock traded hands, compared to its average volume of 1,123,775. The company has a 50-day simple moving average of $14.34 and a two-hundred day simple moving average of $11.09. The company has a market cap of $565.79 million, a price-to-earnings ratio of -146.13 and a beta of 2.35. Aehr Test Systems has a 1-year low of $6.27 and a 1-year high of $23.00.

Aehr Test Systems (NASDAQ:AEHR - Get Free Report) last announced its quarterly earnings results on Tuesday, July 8th. The semiconductor company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.01. Aehr Test Systems had a negative net margin of 6.63% and a negative return on equity of 0.15%. The firm had revenue of $14,100 billion during the quarter, compared to analysts' expectations of $14.83 million. Equities research analysts forecast that Aehr Test Systems will post 0.1 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded Aehr Test Systems to a "sell" rating in a research note on Tuesday, May 13th.

About Aehr Test Systems

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.